202 related articles for article (PubMed ID: 8822501)
1. Mechanisms of action of endocrine treatment in breast cancer.
Lønning E; Lien EA
Crit Rev Oncol Hematol; 1995 Nov; 21(1-3):158-93. PubMed ID: 8822501
[TBL] [Abstract][Full Text] [Related]
2. Endocrine therapy in metastatic breast cancer.
Kimmick GG; Muss HB
Cancer Treat Res; 1998; 94():231-54. PubMed ID: 9587691
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
Newby JC; Johnston SR; Smith IE; Dowsett M
Clin Cancer Res; 1997 Sep; 3(9):1643-51. PubMed ID: 9815855
[TBL] [Abstract][Full Text] [Related]
4. Endocrine resistance: what do we know?
Miller TW
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714450
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
6. Novel endocrine therapies in breast cancer.
Klijn JG; Setyono-Han B; Bontenbal M; Seynaeve C; Foekens J
Acta Oncol; 1996; 35 Suppl 5():30-7. PubMed ID: 9142962
[TBL] [Abstract][Full Text] [Related]
7. Hormonal therapy of breast cancer.
Locker GY
Cancer Treat Rev; 1998 Jun; 24(3):221-40. PubMed ID: 9767736
[No Abstract] [Full Text] [Related]
8. Endocrine therapy of endometrial cancer.
Lentz SS
Cancer Treat Res; 1998; 94():89-106. PubMed ID: 9587684
[No Abstract] [Full Text] [Related]
9. Anti-tumor effects of letrozole.
Miller WR; Anderson TJ; Dixon JM
Cancer Invest; 2002; 20 Suppl 2():15-21. PubMed ID: 12442345
[TBL] [Abstract][Full Text] [Related]
10. [Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC].
Mauriac L; Blanc-Vincent MP; Luporsi E; Cutuli B; Fourquet A; Garbay JR; Giard S; Spyratos F; Zafrani B; Dilhuydy JM
Bull Cancer; 2000 Jun; 87(6):469-90. PubMed ID: 10903789
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health.
Journé F; Body JJ; Leclercq G; Laurent G
Expert Opin Drug Saf; 2008 May; 7(3):241-58. PubMed ID: 18462183
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitors: rationale for use following antiestrogen therapy.
Yue W; Santen RJ
Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
[TBL] [Abstract][Full Text] [Related]
13. Biological rationale for endocrine therapy in breast cancer.
Miller WR
Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):1-32. PubMed ID: 14687595
[TBL] [Abstract][Full Text] [Related]
14. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and the endometrium.
Barakat RR
Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
[No Abstract] [Full Text] [Related]
16. The duration of adjuvant tamoxifen therapy.
Bilimoria MM; Jordan VC
Cancer Treat Res; 1998; 94():181-93. PubMed ID: 9587688
[No Abstract] [Full Text] [Related]
17. [Breast neoplasms: predictive factors for endocrine therapy ].
Hayashi S
Nihon Rinsho; 2007 Jun; 65 Suppl 6():148-53. PubMed ID: 17682151
[No Abstract] [Full Text] [Related]
18. The clinical relevance of endocrine-therapy-induced changes in lipid metabolism in breast cancer patients.
Frassoldati A; Guarneri V; Conte P
Cancer Biol Ther; 2009 Aug; 8(15):1456-8. PubMed ID: 19617703
[No Abstract] [Full Text] [Related]
19. Selecting adjuvant endocrine therapy for breast cancer.
Eneman JD; Wood ME; Muss HB
Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer.
Lykkesfeldt AE
Acta Oncol; 1996; 35 Suppl 5():9-14. PubMed ID: 9142958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]